Genetic risk for psychiatric illness is complex, so identification of shared molecular pathways where distinct forms of genetic risk might coincide is of substantial interest. A growing body of genetic and genomic studies suggest that such shared molecular pathways exist across disorders with different clinical presentations, such as schizophrenia and autism spectrum disorder (ASD). But how this relates to specific genetic risk factors is unknown. Further, whether some of the molecular changes identified in brain relate to potentially confounding antemortem or postmortem factors are difficult to prove. We analyzed the transcriptome from the cortex and hippocampus of three mouse lines modeling human copy number variants (CNVs) associated with schizophrenia and ASD: Df(h15q13)/+, Df(h22q11)/+, and Df(h1q21)/+ which carry the 15q13.3 deletion, 22q11.2 deletion, and 1q21.1 deletion, respectively. Although we found very little overlap of differential expression at the level of individual genes, gene network analysis identified two cortical and two hippocampal modules of co-expressed genes that were dysregulated across all three mouse models. One cortical module was associated with neuronal energetics and firing rate, and overlapped with changes identified in postmortem human brain from SCZ and ASD patients. These data highlight aspects of convergent gene expression in mouse models harboring major risk alleles, and strengthen the connection between changes in neuronal energetics and neuropsychiatric disorders in humans.
Introduction
The complex and highly polygenic nature of psychiatric disorders [1, 2] makes it difficult to connect genetic risk factors to brain function [3] . One way of addressing this issue is by collecting large sample sizes that can capture patterns of convergence among many individuals with these disorders. For example, transcriptomic studies in humans suggest that despite having diverse genetic etiologies and no gross pathology, patients with major psychiatric disorders have recognizable, partially overlapping patterns of dysregulation in gene expression [4] [5] [6] [7] .
Another avenue of research is to focus on the rare, but relatively highly penetrate forms of these disorders [3] . In severe mental disorders, including in schizophrenia (SCZ), an important subset of these rare highly penetrate forms [8] is copy number variation (CNV) [2] . Published studies indicate that between 2.5 and 5% of SCZ patients carry one of the eight CNVs most frequently associated with SCZ [2] . These CNVs have relatively high penetrance compared with common variants and have clearly defined and evolutionary conserved genomic structure [2, 9] , which makes them well suited for generating mouse models to study the brain mechanisms underlying neuropsychiatric disease risk [9] [10] [11] . In addition, all of these CNVs have pleotropic effects, variably increasing risk for a range of neurodevelopmental outcomes, including intellectual disability (ID), autism spectrum disorder (ASD), and SCZ [3, 12, 13] . Such pleiotropy has been the rule, rather than the exception for most major effect risk genes [3, 12] . Transcriptomic studies of patients with major psychiatric disorders have largely been based on cases without defined genetic etiologies. Therefore, with the exception of (dup)15q11-13 syndrome and ASD [6] , it is not known whether specific genetic forms of mental disorders show similar patterns of convergence.
To address whether specific genetic variants imparting major risk for SCZ or ASD converge at the molecular level, we leveraged three previously published mouse models with CNVs carrying significant risk for these disorders, Df(h15q13)/+ [14] [15] [16] , Df(h22q11)/+ [17] , and Df (h1q21)/+ [18] , which harbor the 15q13.3 deletion [19] , 22q11.2 deletion [13] , and 1q21.1 deletion [2] , respectively. These three models have strong construct validity as they all harbor deletions of regions homologous to those found in human deletions associated with SCZ and ASD [2, 9, 13] . Of note, these mice were tested for face validity with respect to phenotypic aspects of SCZ and ASD. For example, Df(h1q21)/+ mice display abnormalities in the dopaminergic pathway [18] which has been implicated in SCZ [20, 21] . Both Df(h15q13)−/− and Df(h15q13)/+ mice, which have qualitatively similar phenotypes [9, 14] displayed phenotypes analogous to some of the negative symptoms and electrophysiological abnormalities seen in SCZ patients [14] [15] [16] . In addition, these mice displayed altered social behavior that is often considered similar to changes seen in ASD patients [14] [15] [16] . Df(h22q11)/+ mice displayed a decrease in prepulse inhibition and displayed acquired acoustic startle response similar to that seen in SCZ patients [17, 22] , which could not be rescued by the antipsychotic drugs haloperidol or clozapine [17] commonly used to treat SCZ [23] . While the three mouse models all present neuropsychiatric disease relevant phenotypes, there is substantial phenotypic variability between them, consistent with the individuals carrying these CNVs who present with different diagnoses [24] [25] [26] .
In this study, we aimed to explore whether despite the variability in phenotype there is convergence at the molecular level. The variable phenotypes in SCZ and other psychiatric disorders does not preclude shared molecular pathways, as many psychiatric disorders show overlap in some pathways [4, 5] . We performed genome-wide transcriptome sequencing on both the cortex and hippocampus in adult animals from these three mouse models. These regions were selected as they have both been implicated in the pathophysiology of SCZ [7, [27] [28] [29] [30] [31] [32] , as well as other psychiatric disorders [4, 33, 34] in both humans and in mouse models.
We discovered many significantly differentially expressed (DE) genes in all tissues examined, but found very little overlap between models at the level of standard single gene analyses, even between cortex and hippocampus from the same CNV model. However, examining coordinated transcriptional regulation via gene network analysis revealed modules of genes that were dysregulated across all mouse models. This includes a cortical module associated with mitochondrial function in neurons that was downregulated across all three mouse models. This analysis is the first to show a convergent pattern of gene expression in mouse models harboring mutations increasing risk for SCZ and allied neurodevelopmental disorders, and further strengthens the hypothesis that neuronal energetic dysfunction plays a role in SCZ and related neuropsychiatric disorders [35] .
Methods

Samples
Mice were bred and housed until 8 weeks by Taconic MB (Lille Skensved, Denmark), and then transported to the Lundbeck animal facility. Detailed description of animal housing and handling has been previously described [16] . Adult mice (ranging from 10 to 22 weeks) harboring the CNV as well control littermates were sacrificed by cervical dislocation and parietal cortex or hippocampus were dissected by hand and stored at −80°C. With the exception of Df(h15q13)−/− the cortex and hippocampus were dissected from separate animals. Sample sizes were generally comparable between groups and were based on tissue availability and previously published similar experiments.
A summary of samples passing quality control is listed in Table 1 . All studies were carried out in accordance with Danish legislation, granted by the animal welfare committee, appointed by the Danish Ministry of Food, Agriculture and Fisheries-Danish Veterinary and Food Administration. Samples were lysed and homogenized in RA1 lysis buffer with 1% β-mercaptoethanol (Macherey-Nagel, Düren, Germany) using a PT 1200 E Polytron® (Kinematica, Luzern, Switzerland). Total RNA was purified using Tru-Seq® Stranded mRNA Sample Preparation kit according to manufacturer's instructions (Illumina, San Diego, Ca, USA). RNA quality was assessed by measuring RNA integrity (RIN) values and absorption spectra on an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). 3′ poly-adenylation purification, adapter ligation, and PCR amplification was carried out using the TruSeq® Stranded mRNA Sample Preparation kit per manufacturer's instructions, with a minimum amount of 160 ng RNA per sample (Illumina).
Sequencing
Samples were multiplexed and genotypes were balanced on lanes and flow cells per study. Samples were sequenced by 50 bp single reads or 100 bp paired reads on Illumina HiSeq (Illumina). See sequencing details for each dataset in Supplementary Table 1 . Sequencing quality was assessed using fastQC (http://www.bioinformatics.babraham.ac.uk/ projects/fastqc/). Reads were mapped to GRCm38 using Gencode v11 via STAR [36] . Gene expression levels were quantified using the featureCounts function from subread [37] . Alignment, GC bias and duplication metrics were collected using Picard tools (http://broadinstitute.github.io/ picard/) functions CollectRnaSeqMetrics, CollectGcBias-Metrics, and MarkDuplicates, respectively, and were then aggregated using MultiQC [38] . Genes with less than ten reads in over 80% of the samples were filtered out, resulting in 13,724 genes being retained for further analysis. Samples were then split by study and outlying samples were defined as having standardized sample network connectivity Z scores < −2 [39] and were removed. Code used for the analyses is available at https://github.com/dhglab/mousemodels-harboring-CNVs.
Differential gene expression
Differential gene expression was performed on each tissue from each mouse line separately. Expression values were normalized using the trimmed mean of M-values method from the edgeR package [40] followed by voom from the limma package [41] . The model used for the DE included the following covariates:~Genotype + SeqPC1-SeqPC5. SeqPCs are the first five principal components calculated from the Picard sequencing statistics and are used to control for technical variation introduced during sequencing. For one of the dataset (labeled study 2) only four SeqPCs were used due to available degrees of freedom. The MDS plots of the data pre-and post-regression of the sequencing and biological covariates can be found in Supplementary Fig. 1 . Differentially expressed genes were then defined as having a p value < 0.005 using the limma package [41] , a threshold that we and others have previously validated [42] [43] [44] [45] [46] [47] [48] . The number of genes with FDR < 0.05 is also presented in Supplementary Fig. 2A .
Weighted gene co-expression network analysis
Hemizygous samples and their matching controls were used to construct gene co-expression networks. The sequencing covariates were first regressed out of the expression data.
The CNV region was also regressed out while retaining the information regarding the genotype (wt/hemizygous) of the animal to allow us to study common perturbations across all CNVs ( Supplementary Fig. 1 ). The network was constructed using the Weighted Gene Co-expression Network Analysis (WGCNA) package [49] in R for each tissue individually. A soft threshold was chosen to achieve approximate scale-free topology (R 2 > 0.8) [49] resulting in a soft threshold of four for the cortical network and five for the hippocampal network. The network was then constructed using a topological overlap dissimilarity matrix with a signed network and the "bicor" correlation function from the WGCNA package. A dendrogram was created using hierarchical clustering and the modules were defined as branches of this dendrogram using the hybrid dynamic tree-cutting method [50] using a cutHeight of 0.9999. A deepSplit of 2 and minClusterSize of 100 were used for the cortical network while a deepSplit of 4 and minClusterSize of 160 were used for the hippocampal network. Modules were then merged based on a cutHeight of 0.1 using the mergeCloseModules function.
To relate these modules to traits, the first principal component of the module (the module eigengene) was related to genotype (wt/hemizygous), using a linear model. Modules were considered to be associated with the phenotype when FDR < 0.1. Module hub genes were defined as being those most highly correlated to the module eigengene (kME > 0.7). The top 15 hub genes are plotted along with their top intra-connections.
Rank-rank hypergeometric test
We performed a rank-rank hypergeometric test as previously described [51] . Genes were ranked according to their logFC before running the rank-rank hypergeometric overlap test to evaluate overlap between two datasets.
Gene set enrichment
Gene ontology analysis was performed used GO-Elite [52] with default settings and 20,000 permutations. The top five biological process and molecular function categories were plotted selected from categories containing at least 20 genes of which at least five gene overlapping the test dataset. The denominator for the enrichment was all expressed genes in the tissue (all genes passing the filtering cutoff from the tissue).
Other gene set enrichment including cell type enrichment were performed using Fisher's exact test. The cell type enriched genes were obtained from sorted cells [53] . All other datasets are described in the relevant text. P values were corrected for multiple testing using Benjamini-Hochberg FDR method [54] . For single cell enrichment, the Expression Weighted Cell Type Enrichment (EWCE, https://github.com/ NathanSkene/EWCE) [55] was used in conjunction with single cell data from mouse cortex and hippocampus [56] . EWCE was run with 10,000 bootstrap repetitions on both levels of cell types. When comparing mouse and human datasets mouse genes were converted from human genes based on their ensembl gene ID using bioMart annotation of homologous genes between mouse and human [57] .
GWAS enrichment
GWAS enrichment was performed as previously described [5] on modules significantly associated with genotype (wt/ hemizygous). To test for enrichment, a stratified LD score regression [58] was used. SNPs were assigned to a module if they were within 10 kb of a gene in the module. Enrichment was calculated as the proportion of SNP heritability accounted for by each module divided by the proportion of total SNPs within the module. Significance was tested using a jackknife method, followed by FDR correction. Enrichment was tested in GWAS from ASD [59] , SCZ [60] , bipolar disorder (BD) [1] , and major depressive disorder (MDD) [61] .
Firing rate
Neurons were grouped into two groups, slow and fast spiking neurons, based on Sugino et al. [62] . The module eigengene was calculated for each of the cell types based on microarray data from the same study (GSE2882) [62] . The two groups of neurons were compared using a two-sided non parametric Mann-Whitney-Wilcoxon test [63] .
Protein-protein interactions
Protein-protein interactions (PPI) were mapped using the Dapple [64] module version 0.17 in GenePattern (http:// genepattern.broadinstitute.org) with default settings.
Module preservation
Module preservation was performed to test whether the modules identified in the hemizygous mice were also found in the homozygous 15q13.3 deletion mice, which was not used to construct the network. A Z-summary statistic that aggregates many preservation measurements [65] , based on 200 permutations, was used to determine preservation. Modules with 2 < Z summary < 10 were considered moderately preserved while modules with Z summary > 10 were considered strongly preserved. Modules with Z summary < 2 were not considered to be preserved.
Mean gene rank test
The mean gene rank test was performed as previously described [44] . For each gene set we measured the average ranking of the DE genes in all the datasets ranked by their pvalues. The average ranking was normalized as follows:
Total number of genesÞ such that if all DEG were at the top of the list the score would approach 1 and a random distribution of them throughout the list would results in score of 0.5. A p-value was calculated using 10,000 permutations which was then corrected for multiple testing using the Benjamini-Hochberg false discovery rate [54] .
Results
Differential gene expression in the CNV/tissue combinations
We sequenced the transcriptome of both the cortex and hippocampus, two regions that have been implicated in SCZ [66] , from three different mouse lines with hemizygous deletions modeling human CNVs Df(h22q11)/+ [17] , Df (h1q21)/+ [18] , and Df(h15q13)/+ [14] , as well as mice carrying the homozygous deletion Df(h15q13)−/− [16] . These mice model the 22q11.2, 1q21.1, and 15q13.3 human CNVs, respectively [14, [16] [17] [18] . We analyzed differential gene expression in each CNV/tissue combination separately ( Fig. 1a ), comparing the transgenic mice to matched littermate controls. The magnitude of DE genes was similar between the hemizygous mice harboring the three different CNVs (84 and 135 in Df(h22q11)/+ cortex and hippocampus, 199 and 26 in Df(h1q21)/+ cortex and hippocampus, and 72 and 48 in in Df(h15q13)/+ cortex and hippocampus), whereas the 15q13.3 homozygous samples displayed a much larger number of DE genes in both the cortex and hippocampus (476 and 564, respectively) ( Fig. 1a , Supplementary Fig. 2A, B and Supplementary  Table 2 ), consistent with its more pronounced behavioral and physiological phenotypes [16] . Each CNV manifested a unique pattern of transcriptomic changes, as there was little overlap in DE genes across the CNVs (Fig. 1b, d) .
Consistent with this, the top GO terms did not overlap between the different CNV/tissue combinations (Supplementary Fig. 2C ). Close examination of the CNVs showed that 90-100% of the expressed genes in each of these loci were significantly downregulated in the corresponding mice and most showed a dosage dependent reduction in expression in the hemizygous mice (logFC of approximately −1 which is equivalent to 50% reduction) ( Fig. 1c ) as has been observed in humans with 22q11.2 deletion [67] . In the homozygous, Df(h15q13)−/− mouse, gene expression was reduced by 97-99.9%, essentially eliminating expression of these genes (Fig. 1c ).
Overlap between the differentially expressed genes across regions and between distinct CNV
We next tested for overlap of genes identified as DE between the hippocampus and cortex across the various CNV combinations and between these two brain regions within a given CNV. The highest overlap was observed between the different brain regions carrying the same CNV ( Fig. 1d ). But, even in this case, only a minority of the genes overlapped. To reduce the effect of using a (arbitrary) p-value or fold-change cutoff, we also compared the mean ranking of DE genes across genotypes and regions (see Methods). This allowed us to compare a list of DE genes from one condition to the entire set of genes from a different condition. We observed significant overlap between the hippocampus and cortex of the hemi-and homo-zygous Df(h15q13) mice, and between the different regions in the Df(h22q11)/− mice (Fig. 1e ). This was also evident by clustering the samples based on the mean effect size rank, where we observed that different tissues from the same CNV clustered together ( Fig. 1e ). Using this analysis, we observed almost no overlap between mice harboring the different CNVs ( Fig. 1e ).
Comparisons with human postmortem gene expression changes in humans
We next wanted to compare the changes in gene expression identified in the different mouse models to those seen in the individuals with different psychiatric disorders. To this end, we compared the DE genes in the cortex of these mice to genes DE in the postmortem cortex of patients with different psychiatric disorders: ASD, SCZ, BD, MDD, alcohol abuse and dependence (AAD), including irritable bowel disease (IBD) as a control [4] . Remarkably, we observed a significant overlap between downregulated genes in the Df(h15q13)−/− mouse cortex and downregulated genes in the cortex from individuals with SCZ (OR = 2.3, FDR = 0.002). But, we could not detect any significantly overlap in the downregulated genes from any of the hemizygous mice ( Fig. 2a ).
Since using an arbitrary p-value cutoff to compare lists of genes results in loss of information and is dependent on power, we also performed a rank-rank hypergeometric test [51] , which utilizes a sliding scale on both test and reference gene lists. Using this more sensitive test that comes closer to assessing genes as a group, we observed a significant overlap between genes downregulated in the cortex of the different mouse models in our study and genes downregulated in the cortex of patients with ASD (Df(h15q13)−/+ p = 6.98e-15, Df(h15q13)−/− p = 7.45e-21, Df(h1q21)/+ p = 1.73e−25, and Df(h22q11)/+ p = 9.71e−33; bottom left corner of each plot in Fig. 2b) . These overlapping downregulated genes were associated with GO terms related to neuronal function (Fig. 2c ). This finding is consistent with previous data showing that the genes downregulated in ASD and SCZ are generally associated with neuronal signaling [4, 6] .
Network analysis identifies gene modules shared across CNVs
We reasoned that a gene network approach, by assessing co-regulated, functional groups of genes, rather than analysis of individual gene DE, would be a more powerful method to detect convergence between the different mouse models [68] . To this end, we constructed a region specific co-expression network using WGCNA [49] . We removed CNV region specific effects by regressing out the CNV along with technical sequencing covariates ("Methods" section; Supplementary Fig. 1) , while retaining the effect of genotype (wt/hemizygous). As transcription was considerably more affected in the homozygous Df(h15q13)−/− causing them to be relative outliers (Fig. 1a) , we only used the hemizygous and wt mice transcriptome to construct the network. Analysis of the cortical network ( Fig. 3a and Supplementary Table 3 ) revealed two modules significantly associated with genotype (FDR < 0.1), which were regulated in the same direction across all CNVs: the upregulated cortical module 1 (cM1; adjusted R 2 = 0.42, FDR < 0.1) and the downregulated cortical module 2 (cM2; adjusted R 2 = −0.36, FDR < 0.1; Fig. 3b ). Examining the module eigengene of each sample for both of these modules showed that they were not driven by a single CNV, but rather showed similar dysregulated patterns across the all mouse models (Fig. 3c) .
To characterize these modules, we performed GO term enrichment (Fig. 3d ). The upregulated cM1 was enriched for genes that were linked to cell morphology (i.e., "morphogenesis of branching structures" and "pattern specification process"), whereas the downregulated cM2 was enriched for genes linked to mitochondrial related energy balance (i.e., "energy coupled proton transport" and "respiratory electron transport chain"; e.g., hub genes Slc25a3, Idh3a, Atp5b; Fig. 3d, e ). Testing for cell type enrichment revealed that while cM1 was not enriched for genes from a single cell type, cM2 was significantly enriched for neuronal genes (OR = 2.3, FDR < 0.005) and myelinating oligodendrocyte genes (OR = 2, FDR < 0.005; Fig. 3f ). Neither modules were enriched for DEG from any of the mouse models (data not shown).
To test whether these modules were relevant to human disease, we measured whether they were enriched for dysregulated genes in postmortem cerebral cortex from patients with psychiatric disorders [4] . The upregulated cM1 was only enriched for genes upregulated in AAD [4] (OR = 3.3, FDR = 0.01). Conversely, the downregulated cM2 was significantly enriched for genes downregulated in ASD [4] (OR = 3, FDR = 3e−13), SCZ [4] (OR = 3, FDR = 3e−13), and to a lesser extent, in colon biopsies taken from patients with IBD [4] (OR = 1.4, FDR = 0.008) (Fig. 3g) . Since these modules were constructed from data coming from models of rare variation associated with SCZ, we reasoned that it would be important to know whether they were enriched for common variation associated with psychiatric disorders. We tested for enrichment of SNP heritability on the basis of GWAS results from ASD [59] , SCZ [60] , BD [1] , and MDD [61] and found significant enrichment in cM2 for SCZ GWAS (enrichment = 1.8, FDR = 0.02). We next compared our modules to those found in a psychiatric cross disorder transcriptomic study [5] . cM1 was enriched for two modules, geneM23 (OR = 8.1, FDR < 0.01) and geneM31 (OR = 11, FDR < 0.005; Fig. 3i ), which is a module upregulated across ASD, SCZ, and BD [5] . cM2 overlapped with gene modules geneM1 (OR = 2.5, FDR < 0.005), geneM7 (OR = 2, FDR < 0.05) and geneM33 (OR = 6.5, FDR < 0.005) (Fig. 3i) , all of which are modules enriched in neurons and for mitochondrial processes. Interestingly, the previously identified geneM7 was also enriched for both SCZ and BD GWAS signals [5] . We also analyzed the hippocampal co-expression network ( Supplementary Fig. 3A and Supplementary Table 3 ) and identified ten modules that were significantly associated with genotype ( Supplementary Fig. 3B ). Two of the modules were dysregulated in the same direction in all CNVs ( Supplementary Fig. 3C ). hM1 was most enriched for GO terms related to unfolded protein binding, whereas hM2 module was most enriched for terms related to nucleosome organization ( Supplementary Fig. 3D, E) . Testing for enriched for common variation associated with psychiatric disorders revealed that none of the hippocampal modules were enriched for GWAS results ( Supplementary Fig. 3F ). We did not perform the other enrichments tests as the underlying data (i.e., cell types and disorder related modules) were all derived from cortex [4, 5, 53] and did not have hippocampal equivalents.
We next wanted to test the overlap between the cortical and hippocampal modules significantly associated with genotype. Comparing the hippocampal and cortical modules revealed that the cortical modules significantly associated with genotype (cM1 and cM2) showed significant overlap with hippocampal modules; cM1 overlapped with hM7 (OR = 4.4, FDR = 1.67e−02) and cM2 overlapped with both hM4 and hM5 (OR = 3.2, FDR = 6.69e−5 and OR = 2.3, FDR = 2.85e−2 respectively; Supplementary Fig. 4A ). However, the overlapping hippocampal modules (hM7, hM4, and hM5), as well other hippocampal modules enriched for mitochondria function (hM8 and hM10) do not appear to be dysregulated in a consistent manner across the mouse models ( Supplementary Fig. 3C ). This suggests that either the hippocampal signal is weaker and less consistent, or the analysis underpowered, or that the convergence observed in the cortex may be region specific.
To validate our network, we tested whether the modules identified replicated in another dataset. To this end, we conducted preservation analysis using the Df(15q13)−/− homozygous mice, which were not used to construct the network. In the cortex, cM2 was very strongly preserved (Z summary = 19), whereas cM1 was moderately preserved (Z summary = 7.2; Supplementary Fig. 4B ). Both of these modules were dysregulated in the same direction in the Df (15q13)−/− samples ( Supplementary Fig. 4C ). In the hippocampus, 7 of the 10 modules were strongly preserved ( Supplementary Fig. 4B ). All but two of the preserved hippocampal modules (hM6 and hM7) were dysregulated in the same direction in the Df(15q13)−/− samples (Supplementary Fig. 4C) , consistent with the substantial overall preservation of these patterns.
Characterization of the downregulated cortical mitochondrial module
We further characterized the downregulated cortical module, cM2, which showed a consistent pattern across mutant genotypes and overlapped with patterns observed in SCZ and ASD postmortem brain transcriptomic changes (Fig. 3g, i) and was the only module enriched for GWAS results ( Fig. 3h and Supplementary Fig. 3F ). We first elaborated on the mitochondrial signature found in this module. cM2 was significantly enriched for both classes of transcriptionally distinct mitochondria found in neurons: [69] synaptic mitochondria (OR = 4.79, FDR = 9e−10) and soma enriched neuronal activity-related mitochondria (OR = 5.03, FDR = 1.13e−14; Fig. 4a ). cM2 also significantly overlapped with a neuronal mitochondrial module found to be downregulated in comprehensive transcriptome analysis performed in postmortem tissue from three major psychiatric disorders (ASD, SCZ, BD) [4] (OR = 2.72, FDR = 1.33e−8; Fig. 4a ), further validating its disease relevance and potential generalizability of genes within this module.
To obtain a more detailed picture of which cell types were represented by this module, we performed EWCE [55] using single cell expression data from mouse cortex [56] . We observed the largest enrichment in inhibitory neurons (standard deviations (SD) away from mean = 13.7 and 7.1, FDR < 0.005) with less, but still significant, enrichment in excitatory neurons (SD away from mean = 5; FDR < 0.005; Fig. 3 Network analysis of combined cortical data from the different CNVs. a Cortical network dendogram of genes across the different CNVs with module assignment. Color bar shows correlation to genotype. b Adjusted R-squared modules significantly associated with genotype across all CNVs with FDR < 0.1. c Module eigengene (ME) of modules significantly associated with genotype. d GO terms enriched in modules significantly associated with genotype. Red lines represent the Z-score = 2 cutoff. e Network plots of the top 15 hub genes with the top 50 connections between them for modules significantly associated with genotype. f CNS cell type enrichment. Values are fold enrichment. ***FDR < 0.005 g Enrichment of differentially expressed genes from different neurodevelopmental and psychiatric disorders from Gandal et al. [4] in the modules significantly associated with genotype. Values are fold enrichments and FDR values are in parentheses. h Enrichment for GWAS for ASD [59] , SCZ [60] , BD [1] , and MDD [61] using stratified LD score regression (FDR < 0.05). i Overlap of modules significantly associated with genotype with cross disorder genes modules [5] . *FDR < 0.05, ** < 0.01, *** < 0.005. MO myelinating oligodendrocyte Fig. 4b and Supplementary Fig. 5 ). Due to the association of neuronal firing rate with cellular energetics and mitochondrial genes [69] , we hypothesized that this module was related to neuronal firing rate. We calculated the module eigengene for the different neuron types [62] and classified the neurons based on the firing rate using current clamp measurements from the same study [62] . We observed a significant increase in the expression of cM2 genes (as measured by the module eigengene) in fast firing inhibitory neurons compared to slower firing neurons (p < 0.005; Fig. 4c ) [69] .
To further validate this module as representing a biologically coherent process, we analyzed the PPI of the genes found in this module. The resulting network showed a significant enrichment for PPI (p = 0.001), demonstrating that this module represents a biologically relevant functional unit. The PPI network structure revealed two functional clusters within this module, a mitochondrial cluster containing many NDUF proteins and a proteasome-mitochondrial-related cluster containing many PSM proteins (Fig. 4d ) further confirming the biological relevance of this module.
Discussion
Studies of individual mouse models of psychiatric disorders, or single brain regions have been conducted [9, 32, [70] [71] [72] , but no study has performed a comprehensive functional genomics comparison across several models to assess convergence. We aimed to determine whether the patterns of changes in gene expression in the brains of mice carrying CNVs that increase risk for SCZ and other psychiatric disorders were distinct or overlapping. We found that each CNV results in a unique pattern of DE genes not only between CNVs, but also between different brain regions within the same animal model. Despite these differences, network analysis allowed us to identify a key point of convergence: a gene module that was dysregulated in the cortex across all CNVs. This neuronal mitochondrial module, termed cM2, overlaps with changes previously observed in SCZ and ASD in human postmortem brain [73] [74] [75] , and overlaps with genes related to interneurons and correlated with neuronal firing rate, highlighting its broader relevance to humans with these disorders and not only to those harboring these specific CNVs. The observation of the same biological process previously observed in human brain, now in three distinct mouse models, is significant because it eliminates the explanation that the neuronal energetic dysfunction observed in humans reflects a postmortem artifact [76, 77] . Here, the well-controlled experimental design, lack of antemortem illness, absence of drug treatments, rapid processing of tissue, and high RNA integrity, control for confounders that confront interpretation of postmortem human studies. Rather, the GWAS enrichment and the absence of the aforementioned confounders in the current study suggest a role for this process in SCZ.
Face validity
We recognize that no single model is a replica of a human psychiatric disorder. At the same time, the relation between the CNV and potential human disease-related phenotypes in these models, so called "face validity," is of interest [10] . As previously shown, there is little similarity between the disease relevant behaviors in the three mouse models studied [9] . This is consistent with the individuals carrying these CNVs [78] , as well as the gene expression patterns observed in this study. At the gene expression level, we found that the GO terms associated with DE genes identified in this study were often related to previous findings in patients with these CNVs. For example in the Df(h22q11)/+ mice the DE genes were enriched for calcium ion related GO terms ("calcium ion binding" and "cellular response to calcium ion") a finding that has been replicated in another study [79] and may be linked to the hypocalcemia seen in many 22q11 deletion carriers [80] . Another example is the GO term associated with histone modifiers ("histone deacetylase binding"), which was enriched in the Df(h22q11)/+ mouse cortex and have been linked to the pathophysiology seen in patients with a 22q11.2 deletion [81] .
Convergence on mitochondria and neuronal activity between CNVs
Gene network analyses, which considers patterns of coregulated genes [49] , revealed two cortical and two hippocampal modules that were dysregulated in all three models. The cortical module, cM2, is of special interest, as it was enriched for SCZ GWAS results and changed in the same direction in ASD and SCZ postmortem brain, supporting its broader relevance to ASD and SCZ. cM2 is related to neuronal firing rate, and showed a significant enrichment for inhibitory and, to a lesser extent, excitatory neuronal genes as well as for GO terms related to mitochondrial activity (i.e., "energy coupled proton transport"). Moreover, the top hub genes of cM2 contain primarily neuronal (Nefh, Elavl4, Dclk, Cend1, Ina, and Chga) and mitochondrial (Atp5b, Slc25a3, Bcat1, Idh3a) genes. cM2 also significantly overlapped with neuronal-activity dependent and synaptic mitochondrial modules that were previously defined in mouse [69] , as well as with a neuronal mitochondria module that is downregulated in postmortem brain from patients with ASD and SCZ [4, 5] . These enrichments, together with the increase in the expression of cM2 in fast firing neurons, lead us to annotate this module as a "neuronal-associated mitochondrial", or "neuronal energetics" module associated with psychiatric disorders.
In neurons, mitochondria play multiple roles including producing the energy that is required to maintain the resting membrane potential, axonal transport and vesicle recycling and docking [82] , as well as regulating calcium concentration in dendritic spines [82] . In SCZ, it has been suggested that mitochondrial dysfunction impairs energy balance, as well as the ability of neurons and glia to resist and adapt to environmental stressors and their ability to undergo synaptic changes associated with plasticity [83] . The increase of cM2 gene expression in typical fast firing neurons suggests that this module is linked to energy production aspects of mitochondrial function required for maintaining rapid neuronal firing rates that are most prominent in certain classes of interneurons.
The identification of a neuronal energetics module corroborates multiple lines of genetic [73] , metabolic [74] , anatomic [75] , and functional [84] evidence linking mitochondrial dysfunction to SCZ. For example, postmortem brain studies show that mitochondrial structure and function are altered in SCZ, and have also identified a reduction in the number of mitochondria in neurons [35, 75] . The association of SCZ and mitochondrial function is also supported by the presence of 28 mitochondrial related genes among the 108 GWAS loci for SCZ [85] [86] [87] , which is consistent with our finding of enrichment of SCZ GWAS signals in cM2. Combined, these multiple lines of evidence, suggest a causal role for this pathway in the pathophysiology of SCZ.
The overlap of the genes in this neuronal mitochondrial module with downregulated genes in both SCZ and ASD suggests that mitochondrial dysfunction is not unique to SCZ, but rather may be shared across multiple psychiatric disorders even in the absence of these CNVs. This is in line with the pleiotropic nature of these CNVs [13, 88] and is concordant with emerging evidence linking mitochondria dysfunction in neurons across several psychiatric disorders [4, 83] . Consistent with this, recent mega analyses of postmortem brains across six psychiatric disorders found neuronal mitochondrial modules that were downregulated in ASD, SCZ, and BD [4, 5] , which highly overlap with the mitochondrial module identified in this study. While we were able to detect this point of convergence between the three mouse models, this pathway will not explain all of the diverse behaviors observed in these models. Many of the modules did not converge between the three mice models and it will be important to test the effects of both the converging and diverging pathways on SCZ-related behaviors in these models in the future.
Our results link mitochondria across the studied CNV models, and more broadly across relevant human neuropsychiatric disorders even in those without these CNVs. However, these data do not delineate the mechanism(s) by which dysfunctional neuronal energetics may lead to SCZ or ASD, or may be a consequence of neuronal dysfunction associated with these disorders. Transcriptomic studies in other mouse models of psychiatric disorders will be very useful to assess the generalizability of this finding and to dissect the timeline over which these abnormalities arise and disorder specific features. It will also be important to complement transcriptomic studies with physiological measurements and assays of mitochondria function over time in mouse models. In this vein, a recent study demonstrated that mice with a partial 22q11.2 deletion display mitochondrial dysfunction which precedes disruption of axon and neurite development which lead to reduced cortical connectivity [89] . Further support for the role of neuronal energetics comes from another study in Drosophila showing that reduction of two genes, SLC25A1 and SLC25A4, related to the 22q11 locus showed a reduction of the mitochondrial pool at the synapse [90] . Our results suggest that the mouse models used in this study could be used to further assess the role and relationship of mitochondrial dysregulation and neuronal activity in cognitive and behavioral phenotypes. A recent paper carefully assessing physiological overlap in four different mouse models of ASD found changes in excitatory-inhibitory balance most consistent with homeostatic changes in synaptic drive [91] , physiological compensation of the kind that could underlie many of the shared transcriptomic changes observed here. Finally, understanding the mechanism by which dysfunctional neuronal energetics may lead to SCZ will be important in assessing the feasibility of developing therapeutics normalizing mitochondrial function for ameliorating disease-related phenotypes.
Data and code availability
Code and data used for DE and for the construction of gene networks can be found at https://github.com/dhglab/mousemodels-harboring-CNVs. Data are available at the NCBI Gene Expression Omnibus (GEO), accession number GSE129891.
